Metabolic Dysfunction-Associated Steatotic Liver Disease (NAFL)

Alias:
Non-Alcoholic Fatty Liver Disease
Fatty Liver
Nonalcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver
Nonalcoholic Steatohepatitis
Steatosis
Nafld
Non-Alcoholic Fatty Liver Disease Without Mention of Non-Alcoholic Steatohepatitis
Metabolic Dysfunction-Related Steatotic Liver Disease
Metabolic Dysfunction-Associated Fatty Liver Disease
Susceptibility to Nonalcoholic Fatty Liver Disease
Metabolic-Associated Fatty Liver Disease
Non-Alcoholic Steatohepatitis
Nafld Without Mention of Nash
Nonalcoholic Fatty Liver
Fatty Degeneration
Nafld Without Nash
Steatohepatitis
Mafld
Masld
Nafl
Nash
Favorite
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Metabolic Dysfunction-Associated Steatotic Liver Disease, also known as non-alcoholic fatty liver disease, is related to liver disease and steatotic liver disease. An important gene associated with Metabolic Dysfunction-Associated Steatotic Liver Disease is MIR122 (MicroRNA 122), and among its related pathways/superpathways are MicroRNAs in cardiomyocyte hypertrophy and miRNAs involved in DNA damage response. The drugs Entecavir and Simvastatin have been mentioned in the context of this disorder. Affiliated tissues include liver and skeletal muscle.
Related ID:
MESH:D065626
ICD11:1912806631

Basic Information

Inheritance
Age of Onset
Prevalence
Related Gene
Related Mouse Models
Reference
MALACARDS
--
Unknown
--
58
654
3

Medical Symptom

#
Categorization
Description
HPO Frequency
Orphanet Frequency
HPO Source Accession
No data available

Gene & Mutation

#
Gene
Function
Score
Mutations
No data available

Related Drugs

Name
CAS Number
Status
Phase
No data available

Disease Model

Category
Name
MGI
Related Gene
Strain of Origin
Publications
No data available

References Literature

Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Comparison
Al agent
Tutorials
Back to top